Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Vertex Pharmaceuticals (VRTX) Stock Moves -1.12%: What You Should Know
09:45pm, Friday, 14'th Oct 2022 Zacks Investment Research
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $293.21, marking a -1.12% move from the previous day.
My Best Stocks to Buy Now and Hold Forever
09:57am, Friday, 14'th Oct 2022 The Motley Fool
These are ideal "forever" stocks.
3 Medical Stocks to Buy in 2022 for Long-Term Resilience
02:11pm, Thursday, 13'th Oct 2022 Zacks Investment Research
Here we discuss two Medical companies, VRTX, ISRG and AMN, that may prove to be wealth creators for investors over the long term on the back of their strong fundamentals.
3 Red-Hot Stocks That Could Continue to Beat the Market
10:30am, Thursday, 13'th Oct 2022 The Motley Fool
Investors are betting on these companies' revenue growth prospects.
The Best Stocks to Invest $5,000 in Right Now
09:52am, Thursday, 13'th Oct 2022 The Motley Fool
These stocks should give investors a big bang for their buck.
3 Red-Hot Stocks That Could Continue to Beat the Market
06:30am, Thursday, 13'th Oct 2022
Investors are betting on these companies' revenue growth prospects.
Biotech Stock Roundup: DICE Up on Study Data, GILD, BIIB's Updates & More
04:34pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
Regulatory and pipeline updates from DICE and RIGL are the key highlights from the biotech sector during the past week.
Vertex Pharmaceuticals' (VRTX) New AAT Corrector Enters Clinic
04:11pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
The FDA clears Vertex's (VRTX) Investigational New Drug application for VX-634, a small molecule AAT corrector, thereby allowing the company to initiate a first-in-human clinical study in healthy volu
2 Breakout Growth Stocks to Buy for the Long Haul
01:37pm, Wednesday, 12'th Oct 2022 The Motley Fool
These unstoppable stocks could be resilient choices to buy and hold in the next bear market and beyond.
Vertex Pharmaceuticals' (VRTX) New AAT Corrector Enters Clinic
01:32pm, Wednesday, 12'th Oct 2022
The FDA clears Vertex's (VRTX) Investigational New Drug application for VX-634, a small molecule AAT corrector, thereby allowing the company to initiate a first-in-human clinical study in healthy volu
Is Seagen Stock a Buy Now?
12:21pm, Wednesday, 12'th Oct 2022 The Motley Fool
It's growing faster than competitors, but headwinds might soon bog it down.
The Best Stocks to Invest $50,000 in Right Now
12:15pm, Wednesday, 12'th Oct 2022 The Motley Fool
These three top stocks are smart buys to consider in the current market and well beyond.
Missed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and Hold
10:00am, Wednesday, 12'th Oct 2022 The Motley Fool
Vertex already generates billions in revenue -- but there may be more to come.
3 Top Biotech Stocks Defying the Bear Market
09:52am, Tuesday, 11'th Oct 2022 The Motley Fool
Bear market, shmear market. These biotech stocks are soaring despite the market downturn.
Top Analyst Reports for NVIDIA, Pfizer & Citigroup
06:30pm, Monday, 10'th Oct 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Pfizer Inc. (PFE) and Citigroup Inc. (C).
